Converge platform provides a single meeting
place for virtual care needs across the care continuum; open
architecture supports third party innovators
Amwell®, (NYSE: AMWL) a national telehealth leader, today
unveiled its next-generation Converge™ telehealth platform at its
annual Client Forum. Born out of the profound shift in telehealth
usage during the COVID 19 pandemic, from transactional to
longitudinal care, this flexible and scalable platform is designed
to provide deeper connectivity between healthcare players with
unmatched simplicity, reliability, and scalability. With the
Converge platform, Amwell’s products, programs, modules and
Carepoint™ devices, as well as applications from leading
innovators, will be available in one place with a single code base,
further enhancing Amwell’s seamless and unified care experience and
strengthening existing patient provider relationships across all
types of care.
“Digital distribution of care is here,” said Dr. Roy Schoenberg,
President and co-CEO, Amwell. “Telehealth morphed, almost
overnight, from a promising technology to an existential platform
in the operation of healthcare – alongside EHRs, claim systems and
e-prescribing. We are witnessing a new consensus that the future
care of any one patient will inevitably involve a mix of physical,
digital and asynchronous/AI-based care. We designed the Converge
platform to support, simplify, and delight patients, clinicians,
and the healthcare tenants around them, as they rapidly embrace
this new balance of care. Its open architecture invites customers
and innovators to extend their reach, and all of us to imagine a
more graceful healthcare experience, with technology on our
side.”
The platform’s open architecture is designed to host and operate
applications from innovators – further enabling rapid progress
towards digitally enabled healthcare. By embracing a diverse group
of developers as part of the platform, clients are able to pick and
choose the capabilities that matter most to them. Examples
include:
- Google Cloud: Leveraging AI and natural language processing
technologies powered by Google Cloud, real-time captioning and
translation services will advance provider choices for patient
education by surfacing related health education materials based on
a patient’s visit. AI-powered tools will engage patients and their
care teams before, during and after visits to drive better health
insights and outcomes.
- TytoCare: Livestream integration enables improved diagnosis and
treatment for virtual visits using the award-winning TytoCare
handheld exam kit featuring built-in visual guidance
technology.
- The Clinic: Providers can request virtual second opinion
services for patients, connecting them to one of 3,500 Cleveland
Clinic physicians in over 550 advanced sub-specialties via the
Amwell platform.
- Biobeat: Offering a wearable, wireless remote patient
monitoring device in two forms: a wrist-monitor for long-term use
and a disposable chest-monitor for short-term use, Biobeat provides
a tool for the continuous monitoring of 15 vital signs including:
blood pressure, heart rate, blood oxygenation and respiratory rate.
Biobeat devices are used by healthcare organizations and pharma
companies globally; a Biobeat app would enable providers to receive
alerts on patient health status and potential deterioration via an
AI-powered, automated real-time early warning score system.
In addition, Amwell offered a peek at its forthcoming Home TV
solution. Developed in collaboration with Solaborate, the Home TV
Carepoint device, powered by advanced AI, is designed to bring
hospital care into the home environment via an easy-to-use TV-based
experience.
“We realize that transformation is all about partnership and
collaboration,” said Dr. Ido Schoenberg, Chairman and co-CEO,
Amwell. “By bringing together Amwell’s best-in-class solutions with
those from across the ecosystem, we are uniquely able to deliver a
solution that both supports a long list of capabilities across the
full care continuum, from episodic to longitudinal care, and
enables native connectivity between all players. We also understand
that these players have unique needs, and these needs will evolve,
so we have built the Converge platform to be highly scalable,
modular and future-ready, giving clients the ability to reimagine
new ways of using telehealth over time.”
“At the start of the pandemic, we integrated telehealth as a way
to meet demand but have quickly realized the need to make
telehealth a permanent component of our care access model,” said
Susan Pleasants, MD, the Chief Medical Informatics Officer with M
Health Fairview. “Core to the success of our program and high
satisfaction rates thus far has been having a virtual care platform
that is fully integrated with our EHR and embedded in our patient
portal. These components have allowed us to create a more simple,
more cohesive user experience for both patients and providers,
while helping us increase efficiency and expand the reach of our
virtual services to other community locations.”
Central to the Converge platform is its enhanced reliability and
simplicity, featuring fast and reliable video and audio connections
and the ability to easily upgrade these core components over time –
ensuring that clients have access to the best connectivity
experience for the future. The platform can be integrated with
existing workflows, EHRs, patient portals, and consumer
experiences, to support the delivery of care no matter where the
patient or provider originates and resulting in faster and easier
deployment. The single platform approach means a unified identity
system that enables a streamlined and regulatory compliant exchange
of information and services across the ecosystem.
“UPMC Health Plan expanded its telehealth capacity during the
pandemic to meet increasing member demand, which quintupled in the
12 months after the start of the pandemic,” said Natasha Khouri,
Associate Vice President, Telehealth Strategy Solutions, UPMC
Health Plan. “The past year has proven that telemedicine can be a
convenient, clinically appropriate means by which to deliver
accessible, high-quality health care to our members and we expect
to continue to add even more virtual care options to further
strengthen member-provider relationships and improve health
outcomes.”
To learn more about the Converge platform visit:
https://business.amwell.com/solution-overview/
About Amwell
Amwell is a leading telehealth platform in the United States and
globally, connecting and enabling providers, insurers, patients,
and innovators to deliver greater access to more affordable, higher
quality care. Amwell believes that digital care delivery will
transform healthcare. The Company offers a single, comprehensive
platform to support all telehealth needs from urgent to acute and
post-acute care, as well as chronic care management and healthy
living. With over a decade of experience, Amwell powers telehealth
solutions for over 2,000 hospitals and over 55 health plan partners
with over 36,000 employers, covering over 80 million lives. For
more information, please visit https://business.amwell.com/.
American Well, Amwell, Converge and Carepoint are registered
trademarks or trademarks of American Well Corporation in the United
States and other countries. All other trademarks used herein are
the property of their respective owners.
Forward-Looking Statements
This press release contains forward-looking statements about us
and our industry that involve substantial risks and uncertainties
and are based on our beliefs and assumptions and on information
currently available to us. All statements other than statements of
historical facts contained in this press release, including
statements regarding our future results of operations, financial
condition, business strategy and plans and objectives of management
for future operations, are forward-looking statements. In some
cases, you can identify forward-looking statements because they
contain words such as “anticipate,” “believe,” “could,” “estimate,”
“expect,” “intend,” “may,” “plan,” “potential,” “predict,”
“project,” “should,” “will,” or “would,” or the negative of these
words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results,
performance, or achievements to be materially different from any
future results, performance or achievements expressed or implied by
the forward-looking statements. Forward-looking statements
represent our beliefs and assumptions only as of the date of this
release. These statements, and related risks, uncertainties,
factors and assumptions, include, but are not limited to: weak
growth and increased volatility in the telehealth market; inability
to adapt to rapid technological changes; increased competition from
existing and potential new participants in the healthcare industry;
changes in healthcare laws, regulations or trends and our ability
to operate in the heavily regulated healthcare industry; our
ability to comply with federal and state privacy regulations; the
significant liability that could result from a cybersecurity
breach; and other factors described under ‘Risk Factors’ in our
Annual Report on Form 10-K for the year ended December 31, 2020 and
our subsequent filings with the SEC. These risks are not
exhaustive. Except as required by law, we assume no obligation to
update these forward-looking statements, or to update the reasons
actual results could differ materially from those anticipated in
the forward-looking statements, even if new information becomes
available in the future. Further information on factors that could
cause actual results to differ materially from the results
anticipated by our forward-looking statements is included in the
reports we have filed or will file with the Securities and Exchange
Commission. These filings, when available, are available on the
investor relations section of our website at investors.amwell.com
and on the SEC’s website at www.sec.gov.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210428005646/en/
Holly Spring press@amwell.com 781.888.8219
American Well (NYSE:AMWL)
Historical Stock Chart
From Aug 2024 to Sep 2024
American Well (NYSE:AMWL)
Historical Stock Chart
From Sep 2023 to Sep 2024